您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Bomedemstat hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Bomedemstat hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Bomedemstat hydrochloride图片
包装:10mg
市场价:10800元

产品介绍
Bomedemstat (IMG-7289) hydrochloride 是一种具有口服活性和不可逆的 lysine-specific demethylase 1 (LSD1) 抑制剂。Bomedemstat hydrochloride 可以增加 H3K4 和 H3K9 的甲基化,然后改变基因表达。Bomedemstat hydrochloride 具有抗癌活性,可抑制癌细胞增殖并诱导细胞凋亡。
别名IMG-7289 hydrochloride
分子式C28H35ClFN7O2
分子量556.07
溶解度DMSO : 250 mg/mL (449.58 mM; Need ultrasonic)
储存条件Store at -20°C, away from moisture
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Bomedemstat (IMG-7289) hydrochloride is an orally active and irreversiblelysine-specific demethylase 1(LSD1) inhibitor. Bomedemstat hydrochloride can increase H3K4 and H3K9 methylation, and then alter gene expression. Bomedemstat hydrochloride shows anti-cancer activities, inhibits cancer cell proliferation and induces apoptosis[1][2].

Bomedemstat selectively inhibits proliferation and induces apoptosis ofJak2V617Fcells by concomitantly increasing expression and methylation of p53[1].
Bomedemstat (50 nM-1 μM; 96 h) enhances survival, induces apoptosis via BCL-XL and PUMA in a TP53-dependent manner, and leads to cell cycle arrest[1].

Apoptosis Analysis[1]

Cell Line:SET-2 cells
Concentration:50 nM, 100 nM, and 1 μM
Incubation Time:96 hours
Result:Decreased levels of the antiapoptotic protein BCL-XL and increased levels of the pro-apoptotic protein PUMA.

Bomedemstat treatment (oral gavage; 45 mg/kg; once daily; 56 d) normalizes or improves blood cell counts, reduces spleen volumes, restores normal splenic architecture, and reduces bone marrow fibrosis[1].

Animal Model:Mx-Jak2V617Fmice[1]
Dosage:45 mg/kg
Administration:Oral gavage; 45 mg/kg; once daily; 56 days
Result:Reduced splenomegaly significantly with a few treated mice normalizing their spleen weight, the 56-day course led to partial restoration of lymph follicles and spleen architecture by histological examination.